Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611111200 on June 1, 2007

J. Biol. Chem., Vol. 282, Issue 32, 23591-23602, August 10, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/32/23591    most recent
M611111200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tordjman, J.
Right arrow Articles by Antoine, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tordjman, J.
Right arrow Articles by Antoine, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cytosolic Aspartate Aminotransferase, a New Partner in Adipocyte Glyceroneogenesis and an Atypical Target of Thiazolidinedione*

Joan Tordjman{ddagger}1, Stéphanie Leroyer{ddagger}§2, Geneviève Chauvet{ddagger}, Joëlle Quette{ddagger}§, Caroline Chauvet§3, Céline Tomkiewicz, Charles Chapron**, Robert Barouki, Claude Forest{ddagger}, Martine Aggerbeck, and Bénédicte Antoine{ddagger}§4

From the {ddagger}Inserm U530 and Inserm U747, Université Paris Descartes, F-75006, Paris and **AP-HP Groupe Hospitalier Universitaire Ouest, CHU Cochin, Université Paris Descartes, F-75006, Paris, and §Inserm U680, Université Pierre et Marie Curie-Paris 6, F-75012 Paris, and CNRS, UPR 9078, F-75015 Paris, France

We show that cytosolic aspartate aminotransferase (cAspAT) is involved in adipocyte glyceroneogenesis, a regulated pathway that controls fatty acid homeostasis by promoting glycerol 3-phosphate formation for fatty acid re-esterification during fasting. cAspAT activity, as well as the incorporation of [14C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (TZD) rosiglitazone. Conversely, the ratio of fatty acid to glycerol released into the medium decreased. Regulation of cAspAT gene expression was specific to differentiated adipocytes and did not require any peroxisome proliferator-activated receptor {gamma} (PPAR{gamma})/retinoid X receptor-{alpha} direct binding. Nevertheless, PPAR{gamma} is indirectly necessary for both cAspAT basal expression and TZD responsiveness because they are, respectively, diminished and abolished by ectopic overexpression of a dominant negative PPAR{gamma}. The cAspAT TZD-responsive site was restricted to a single AGGACA hexanucleotide located at -381 to -376 bp whose mutation impaired the specific ROR{alpha} binding. ROR{alpha} ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by rosiglitazone treatment of adipocytes. Finally, the amounts of ROR{alpha} and cAspAT mRNAs were similarly increased by TZD treatment of human adipose tissue explants, confirming coordinated regulation. Our data identify cAspAT as a new member of glyceroneogenesis, transcriptionally regulated by TZD via the control of ROR{alpha} expression by PPAR{gamma} in adipocytes.


Received for publication, December 4, 2006 , and in revised form, May 22, 2007.

* This work was supported in part by INSERM, CNRS, the Université René Descartes, the Association Claude Bernard, and the Association pour la Recherche contre le Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a fellowship from the Ministère de l'Education Nationale et de la Recherche and of the 2003 prize from the French Nutrition Society. Present address: INSERM U755, Paris F-75004, France.

2 Recipient of a fellowship from the Agence Nationale pour la Recherche sur le Sida.

3 Supported by Association pour la Recherche contre le Cancer Grant 3511 (to J.-L. Danan).

4 To whom correspondence should be addressed: INSERM U680, Université Pierre et Marie Curie, Facultéde Médecine, 27, rue de Chaligny, 75012 Paris, France. Tel.: 33-1-4001-1351; Fax: 33-1-4001-1352; E-mail: antoine{at}st-antoine.inserm.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement